COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,373,000 | -16.5% | 69,535 | 0.0% | 0.19% | -16.8% |
Q2 2021 | $1,644,000 | -0.2% | 69,535 | 0.0% | 0.23% | -7.8% |
Q1 2021 | $1,648,000 | +18.3% | 69,535 | 0.0% | 0.24% | +13.4% |
Q4 2020 | $1,393,000 | -3.8% | 69,535 | 0.0% | 0.22% | -4.0% |
Q3 2020 | $1,448,000 | +19.0% | 69,535 | 0.0% | 0.22% | +34.7% |
Q2 2020 | $1,217,000 | +7.1% | 69,535 | 0.0% | 0.17% | -8.2% |
Q1 2020 | $1,136,000 | -20.6% | 69,535 | 0.0% | 0.18% | +16.7% |
Q4 2019 | $1,431,000 | +193.8% | 69,535 | +63.9% | 0.16% | +173.7% |
Q3 2019 | $487,000 | -12.7% | 42,429 | 0.0% | 0.06% | -20.8% |
Q2 2019 | $558,000 | -13.1% | 42,429 | 0.0% | 0.07% | -12.2% |
Q1 2019 | $642,000 | -18.4% | 42,429 | +28.6% | 0.08% | -31.7% |
Q4 2018 | $787,000 | +61.9% | 33,000 | 0.0% | 0.12% | +71.4% |
Q3 2018 | $486,000 | -38.2% | 33,000 | 0.0% | 0.07% | -41.7% |
Q2 2018 | $787,000 | -6.6% | 33,000 | 0.0% | 0.12% | -10.4% |
Q1 2018 | $843,000 | +142.2% | 33,000 | +75.0% | 0.13% | +157.7% |
Q4 2017 | $348,000 | – | 18,857 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |